Vazquez-Martin et al. [38] demonstrated that lapatinib enhanced HER2 extracelluar domain shedding and inhibited HER2 phosphorylation and activity, thereby suppressing HER2-overexpressing cancer cell growth. This evidence concerns the gene ERBB2 and cancer.